NALGESIC 300 mg, film-coated tablet 16 tablets
Active ingredients: FÉNOPROFÈNE, (RS)-fenoprofen calcium
Commercialized according to BDPM
Film-coated tablet16 tabletsorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- NALGESIC 300 mg, comprimé pelliculé
- Pharmaceutical form
- comprimé pelliculé
- Route of administration
- orale
- Presentation description
- 1 plaquette(s) thermoformée(s) PVC aluminium de 16 comprimé(s)
- Marketing authorisation holder
- SCIENCEX
- Reimbursement according to BDPM
- 65%
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 24 Oct 2005
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
68362550CIP73198190CIP133400931981909Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| FÉNOPROFÈNEcomprimé | 300 mg · un comprimé | FT |
| FÉNOPROFÈNE CALCIUMcomprimé | 346,00 mg · un comprimé | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.